Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Development, Implementation and Evaluation of Novel Strategies To Reduce Inappropriate Antimicrobial Use in Community and Healthcare Settings, Funding Opportunity Announcement (FOA) CI08-001, 24291 [E8-9671]

Download as PDF Federal Register / Vol. 73, No. 86 / Friday, May 2, 2008 / Notices along with a notice of a 60-day public comment period for the report. Following the close of the comment period, comments will be addressed and, where appropriate, changes will be incorporated into the report. The public comments and other data submitted in response to the Federal Register notice will bear the docket control number of ATSDR–244 and can be sent via e-mail box greatlakes@cdc.gov. This material is available for public inspection in the Record Room for the Agency for Toxic Substances and Disease Registry, 4770 Buford Highway, Building 106, Atlanta, Georgia 30341 (not a mailing address) between 8 a.m. and 4:30 p.m., Monday through Friday, except on legal holidays. Dated: April 29, 2008. Ken Rose, Director, Office of Policy, Planning, and Evaluation, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry. [FR Doc. E8–9742 Filed 5–1–08; 8:45 am] Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Development, Implementation and Evaluation of Novel Strategies To Reduce Inappropriate Antimicrobial Use in Community and Healthcare Settings, Funding Opportunity Announcement (FOA) CI08–001 mstockstill on PROD1PC66 with NOTICES In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 12 p.m.–3 p.m., May 20, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to ‘‘Development, Implementation and Evaluation of Novel Strategies To Reduce Inappropriate Antimicrobial Use in Community and Healthcare Settings,’’ FOA CI08–001. Contact Person for More Information: Christine Morrison, PhD, Scientific Review Administrator, Office of the Chief Science Officer, CDC, 1600 Clifton Road, NE., Jkt 214001 BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Reducing Prenatal Exposure to Alcohol and Other Co-Occurring Risk Behaviors in the Preconception Period, Funding Opportunity Announcement (FOA) DD 08–003 DEPARTMENT OF HEALTH AND HUMAN SERVICES 17:17 May 01, 2008 Dated: April 28, 2008. Diane Allen, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–9671 Filed 5–1–08; 8:45 am] Centers for Disease Control and Prevention BILLING CODE 4163–70–P VerDate Aug<31>2005 Mailstop D74, Atlanta, GA 30333, Telephone 404–639–3098. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 12:30 p.m.–3:30 p.m., June 18, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to ‘‘Reducing Prenatal Exposure to Alcohol and Other Co-Occurring Risk Behaviors in the Preconception Period,’’ FOA DD 08–003. Contact Person for More Information: Juliana Cyril, PhD, M.P.H., Scientific Review Administrator, Office of the Chief Science Officer, CDC, 1600 Clifton Road, NE., Mailstop D74, Atlanta, GA 30333, Telephone 404–639–4639. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 24291 Dated: April 28, 2008. Diane Allen, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–9347 Filed 5–1–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Addressing Emerging Infectious Diseases in the Republic of India, Funding Opportunity Announcement (FOA) IP 08–009 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 12 p.m.–2 p.m., June 17, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to ‘‘Addressing Emerging Infectious Diseases in the Republic of India,’’ FOA IP 08–009. Contact Person for More Information: Trudy Messmer, PhD, Scientific Review Administrator, Coordinating Center for Infectious Diseases, Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop C19, Atlanta, GA 30333, Telephone 404–639– 2176. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 28, 2008. Diane Allen, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–9515 Filed 5–1–08; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\02MYN1.SGM 02MYN1

Agencies

[Federal Register Volume 73, Number 86 (Friday, May 2, 2008)]
[Notices]
[Page 24291]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-9671]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Development, Implementation and Evaluation of 
Novel Strategies To Reduce Inappropriate Antimicrobial Use in Community 
and Healthcare Settings, Funding Opportunity Announcement (FOA) CI08-
001

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Date: 12 p.m.-3 p.m., May 20, 2008 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
``Development, Implementation and Evaluation of Novel Strategies To 
Reduce Inappropriate Antimicrobial Use in Community and Healthcare 
Settings,'' FOA CI08-001.
    Contact Person for More Information: Christine Morrison, PhD, 
Scientific Review Administrator, Office of the Chief Science 
Officer, CDC, 1600 Clifton Road, NE., Mailstop D74, Atlanta, GA 
30333, Telephone 404-639-3098.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: April 28, 2008.
Diane Allen,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
 [FR Doc. E8-9671 Filed 5-1-08; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.